424B3 1 0001.txt PROSPECTUS SUPPLEMENT RULE NO. 424(b)(3) REGISTRATION NO. 333-95805 REGISTRATION NO. 333-92161 PROSPECTUS SUPPLEMENT (To Prospectus dated January 31, 2000) [LOGO] PHARMACEUTICAL HOLDRS(SM) 1,000,000,000 Depositary Receipts Pharmaceutical HOLDRS(SM) Trust This prospectus supplement amends and supplements information contained in the prospectus dated January 31, 2000 relating to the sale of up to 1,000,000,000 depositary receipts by Pharmaceutical HOLDRS(SM) Trust. The share amounts specified in the table on page 10 of the base prospectus shall be replaced with the following:
Primary Share Trading Name of Company Ticker Amounts Market ---------------------------------- ------ ------- ------- Merck & Co., Inc. MRK 22 NYSE Pfizer Inc. (/1/) PFE 58* NYSE Johnson & Johnson JNJ 13 NYSE Bristol-Myers Squibb Company BMY 18 NYSE Eli Lilly & Company LLY 10 NYSE Schering-Plough Corporation SGP 14 NYSE American Home Products Corporation AHP 12 NYSE Abbott Laboratories ABT 14 NYSE Biovail Corporation (/2/) BVF 2 NYSE King Pharmaceuticals, Inc. (/3/) KG 1.5* NYSE Forest Laboratories, Inc. FRX 1 NYSE Andrx Corporation ADRX 2* NASDAQ Allergan, Inc. AGN 1 NYSE Jones Pharma Inc. JMED 1.5* NASDAQ Watson Pharmaceuticals, Inc. WPI 1 NYSE ICN Pharmaceuticals, Inc. ICN 1 NYSE Mylan Laboratories, Inc. MYL 1 NYSE IVAX Corporation IVX 1.5* AMEX
------- * Reflects previous stock split or business combination transaction. (1) On June 19, 2000, Pfizer Inc. completed its acquisition of Warner-Lambert Company, exchanging 2.75 shares of Pfizer common stock for each share of Warner-Lambert common stock. As a result, the eight shares of Warner- Lambert previously represented in each round-lot of 100 Pharmaceutical HOLDRS have been exchanged for 22 shares of Pfizer. The share amount of Pfizer represented by a round-lot of 100 Pharmaceutical HOLDRS is now 58. (2) On March 16, 2000, Biovail Corporation International changed its name to Biovail Corporation. (3) On May 23, 2000, King Pharmaceuticals, Inc. began trading on the New York Stock Exchange under the symbol "KG". In March 2000, Monsanto Company merged with Pharmacia & Upjohn, Inc., creating the combined company Pharmacia Corporation. As a result, shares of Pharmacia Corporation were distributed to holders of Pharmaceutical HOLDRS and shares of common stock of Pharmacia & Upjohn, Inc. are no longer represented in the Pharmaceutical HOLDRS. The share amounts listed in the table above reflect all previous stock splits. The stock prices in the tables set forth in Annex A of the base prospectus will not be adjusted to account for the stock splits. The date of this prospectus supplement is June 30, 2000.